Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. May 15, 2016; 8(5): 474-480
Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.474
Published online May 15, 2016. doi: 10.4251/wjgo.v8.i5.474
Table 4 Survival by prognostic factor
| Overall survival (%) | ||||
| 1 yr | 3 yr | P value | ||
| Sex | ||||
| Female | 2 | 100 (2) | 100 (2) | 0.017584 |
| Male | 15 | 73 (11) | 47 (7) | |
| Tumor size | ||||
| > 3 cm | 9 | 78 (7) | 44 (4) | 0.34649 |
| < 3 cm | 6 | 83 (5) | 67 (4) | |
| Unknown | 2 | 50 (1) | 50 (1) | |
| Concurrent chemo | ||||
| 5-FU based | 11 | 82 (9) | 55 (6) | 0.078225 |
| Cis based | 6 | 83 (5) | 50 (3) | |
| Tumor configuration | ||||
| > 180 cm | 8 | 63 (5) | 50 (4) | 0.382319 |
| < 180 cm | 9 | 89 (8) | 55 (5) | |
| Node status | ||||
| Negative | 13 | 85 (11) | 62 (8) | 0.009262 |
| Positive | 4 | 75 (3) | 25 (1) | |
| Location of primary tumor | ||||
| 20-35 cm | 12 | 83 (10) | 58 (7) | 0.024229 |
| > 35 ~ | 5 | 80 (4) | 40 (2) | |
| Total | 17 | 82 (14) | 53 (9) | |
- Citation: Zeng M, Aguila FN, Patel T, Knapp M, Zhu XQ, Chen XL, Price PD. Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma. World J Gastrointest Oncol 2016; 8(5): 474-480
- URL: https://www.wjgnet.com/1948-5204/full/v8/i5/474.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i5.474